Pharma & Biotech Smith & Nephew's robotics push wins backing from surgeons and Citi By Oliver Haill 10/06
Pharma & Biotech GSK's Nuvalent deal tackles HIV cliff to win cautious backing from analysts By Oliver Haill 10/06
Medical technology & services Imaging Biometrics sees encouraging Phase 1 trial data By Jamie Ashcroft 09/06
Pharma & Biotech GSK falls as £8bn takeover of Nuvalent is largest deal in a decade By Oliver Haill 09/06
Pharma & Biotech IXICO expands scientific network in Alzheimer’s and Parkinson’s disease By Jamie Ashcroft 08/06
Medical technology & services Imaging Biometrics hails trial validation for brain cancer imaging tool - UPDATE By Ian Lyall 05/06
Pharma & Biotech US bank sees GSK oncology pipeline as major value driver after New York conference By Ian Lyall 04/06
Pharma & Biotech Incanthera shares jump 21% after it acquires Swiss skincare brand and appoints new chief executive - UPDATE By Ian Lyall 04/06
Cannabis Sizing the chronic pain market and the commercial scalability of clinical cannabis By Proactive 03/06
Pharma & Biotech UBS says UK stocks are better supported but not broadly so, as earnings lead while sentiment drags By Ian Lyall 03/06
Pharma & Biotech Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions By Ian Lyall 03/06
Medical technology & services Venture Life shares rise 9% as it acquires US brands FemiClear and CUROXEN for $28m By Jamie Ashcroft 03/06
Pharma & Biotech BSF Enterprise shares fall 31% as tissue engineering firm raises £500,000 at 2p By Ian Lyall 03/06
Medical technology & services Imaging Biometrics says commercial momentum is 'genuine and measurable' By Ian Lyall 03/06
Health Deutsche Bank lifts Applied Nutrition target as strong trading combines with US acquisition By Jamie Ashcroft 02/06
Health Mobia Medical poised for commercial expansion, BofA says in initial coverage By Proactive 02/06
